SCHEMBL9767781

SCHEMBL9767781

CCCCc1nc(Cl)c(CO)n1Cc1ccc(NC(=O)C(Cc2ccc(O)cc2)NC(=O)O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9869151 1.00 — —
SCHEMBL9767564 0.87 AGTR1 (0.53) —
SCHEMBL9871423 0.87 AGTR1 (0.53) —
SCHEMBL9767626 0.84 AGTR1 (0.46) —
SCHEMBL9767407 0.84 AGTR1 (0.46) —
SCHEMBL9767511 0.83 AGTR2 (0.62) —
SCHEMBL9767507 0.83 AGTR2 (0.62) —
SCHEMBL9767531 0.81 AGTR1 (0.55) —
SCHEMBL9767515 0.81 AGTR1 (0.55) —
SCHEMBL352 0.80 AGTR1 (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5045540-A Amide or urea compounds containing imidazole groups WARNER-LAMBERT CO. (US) 1991-09-03 — — US disclosed
US-5041552-A Treatment of hypertension, heart failure, glaucoma and hyperaldosteronism WARNER-LAMBERT COMPANY (US) 1991-08-20 — — US disclosed
Send feedback